Acinetobacter ursingii: Difference between revisions

From IDWiki
Acinetobacter ursingii
(Created page with "{{DISPLAYTITLE:''Acinetobacter ursingii''}} == Background == === Microbiology === * Non-motile, aerobic, oxidase Oxidase::negative, non-fermentative, Stain::Gram-nega...")
 
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
{{DISPLAYTITLE:''Acinetobacter ursingii''}}
 
{{DISPLAYTITLE:''Acinetobacter ursingii''}}
   
== Background ==
+
==Background==
   
=== Microbiology ===
+
===Microbiology===
   
* Non-motile, aerobic, oxidase [[Oxidase::negative]], non-fermentative, [[Stain::Gram-negative]] [[Shape::coccobacillus]]
+
*Non-motile, aerobic, oxidase [[Oxidase::negative]], non-fermentative, [[Stain::Gram-negative]] [[Shape::coccobacillus]]
* Member of the genus [[Acinetobacter species|Acinetobacter]] with low pathogenicity
+
*Member of the genus [[Acinetobacter species|Acinetobacter]] with low pathogenicity
   
=== Epidemiology ===
+
===Epidemiology===
   
* Rare cause of disease in humans
+
*Rare cause of disease in humans
* Mostly affects immunocompromised patients or critically ill patients
+
*Mostly affects immunocompromised patients or critically ill patients
  +
*Possible association with malignancy
   
== Clinical Manifestations ==
+
==Clinical Manifestations==
   
* Primary bacteremia
+
*Primary [[bacteremia]]
  +
*[[Urinary tract infection]]
* Pneumonia
 
  +
*Hospital-associated pneumonia
   
== Further Reading ==
+
== Management ==
   
  +
* Often susceptible, but should still treat broadly (e.g. [[meropenem]]) and narrow based on susceptibilities
* A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of ''Acinetobacter ursingii''. ''BMC Infect Dis''. 2015;15(400). doi: [https://doi.org/10.1186/s12879-015-1145-z 10.1186/s12879-015-1145-z]
 
  +
  +
==Further Reading==
  +
 
*A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of ''Acinetobacter ursingii''. ''BMC Infect Dis''. 2015;15(400). doi: [https://doi.org/10.1186/s12879-015-1145-z 10.1186/s12879-015-1145-z]
  +
*Bacterial Identification, Clinical Significance, and Antimicrobial Susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, Two Frequently Misidentified Opportunistic Pathogens. ''J Clin Microbiol''. 2006;44(12):4471-4478. doi: [https://doi.org/10.1128/JCM.01535-06 10.1128/JCM.01535-06]
   
 
[[Category:Gram-negative bacilli]]
 
[[Category:Gram-negative bacilli]]

Latest revision as of 10:44, 7 February 2021


Background

Microbiology

  • Non-motile, aerobic, oxidase negative, non-fermentative, Gram-negative coccobacillus
  • Member of the genus Acinetobacter with low pathogenicity

Epidemiology

  • Rare cause of disease in humans
  • Mostly affects immunocompromised patients or critically ill patients
  • Possible association with malignancy

Clinical Manifestations

Management

  • Often susceptible, but should still treat broadly (e.g. meropenem) and narrow based on susceptibilities

Further Reading

  • A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii. BMC Infect Dis. 2015;15(400). doi: 10.1186/s12879-015-1145-z
  • Bacterial Identification, Clinical Significance, and Antimicrobial Susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, Two Frequently Misidentified Opportunistic Pathogens. J Clin Microbiol. 2006;44(12):4471-4478. doi: 10.1128/JCM.01535-06